|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 12
2022
Zhu, Zhou; Turner, Nicholas C.; Loi, Sherene; Andre, Fabrice; Martin, Miguel; Dieras, Veronique; Gelmon, Karen A.; Harbeck, Nadia; Zhang, Cathy; Cao, Joan Q.; Yan, Zhengming; Lu, Dongrui R.; Wei, Ping; VanArsdale, Todd L.; Rejto, Paul A.; Huang, Xin; Rugo, Hope S.; Loibl, Sibylle; Cristofanilli, Massimo; Finn, Richard S. und Liu, Yuan
(2022):
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.
In: Npj Precision Oncology, Bd. 6, Nr. 1, 56
Cristofanilli, Massimo; Rugo, Hope S.; Im, Seock-Ah; Slamon, Dennis J.; Harbeck, Nadia; Bondarenko, Igor; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Iwata, Hiroji; O'Leary, Ben; Andre, Fabrice; Loibl, Sibylle; Bananis, Eustratios; Liu, Yuan; Huang, Xin; Kim, Sindy; Frean, Maria Jose Lechuga und Turner, Nicholas C.
(2022):
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2(- )ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study.
In: Clinical Cancer Research, Bd. 28, Nr. 16: S. 3433-3442
Hurvitz, Sara A.; Bachelot, Thomas; Bianchini, Giampaolo; Harbeck, Nadia; Loi, Sherene; Park, Yeon Hee; Prat, Aleix; Gilham, Leslie; Boulet, Thomas; Gochitashvili, Nino; Monturus, Estefania; Lambertini, Chiara; Nyawira, Beatrice; Knott, Adam; Restuccia, Eleonora und Schmid, Peter
(2022):
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer.
In: Future Oncology, Bd. 18, Nr. 32: S. 3563-3572
2021
Aftimos, Philippe; Oliveira, Mafalda; Irrthum, Alexandre; Fumagalli, Debora; Sotiriou, Christos; Gal-Yam, Einav Nili; Robson, Mark E.; Ndozeng, Justin; Di Leo, Angelo; Ciruelos, Eva M.; de Azambuja, Evandro; Viale, Giuseppe; Scheepers, Elsemieke D.; Curigliano, Giuseppe; Bliss, Judith M.; Reis-Filho, Jorge S.; Colleoni, Marco; Balic, Marija; Cardoso, Fatima; Albanell, Joan; Duhem, Caroline; Marreaud, Sandrine; Romagnoli, Dario; Rojas, Beatriz; Gombos, Andrea; Wildiers, Hans; Guerrero-Zotano, Angel; Hall, Peter; Bonetti, Andrea; Larsson, Karolina Fs; Degiorgis, Martina; Khodaverdi, Silvia; Greil, Richard; Sverrisdottir, Asgerdur; Paoli, Marta; Seyll, Ethel; Loibl, Sibylle; Linderholm, Barbro; Zoppoli, Gabriele; Davidson, Nancy E.; Johannsson, Oskar Th; Bedard, Philippe L.; Loi, Sherene; Knox, Susan; Cameron, David A.; Harbeck, Nadia; Montoya, Maite Lasa; Brandao, Mariana; Vingiani, Andrea; Caballero, Carmela; Hilbers, Florentine S.; Yates, Lucy R.; Benelli, Matteo; Venet, David und Piccart, Martine J.
(2021):
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
In: Cancer Discovery, Bd. 11, Nr. 11: S. 2796-2811
Venet, David; Rediti, Mattia; Maetens, Marion; Fumagalli, Debora; Brown, David N.; Majjaj, Samira; Salgado, Roberto; Pusztai, Lajos; Harbeck, Nadia; El-Abed, Sarra; Wang, Yingbo; Saura, Cristina; Gomez, Henry; Semiglazov, Vladimir Fedorovich; de Azambuja, Evandro; Huober, Jens; Nuciforo, Paolo; Di Cosimo, Serena; Piccart, Martine; Loi, Sherene; Rothe, Francoise und Sotiriou, Christos
(2021):
Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial.
In: Clinical Cancer Research, Bd. 27, Nr. 20: S. 5607-5618
2020
Gonzalez-Ericsson, Paula I.; Stovgaard, Elisabeth S.; Sua, Luz F.; Reisenbichler, Emily; Kos, Zuzana; Carter, Jodi M.; Michiels, Stefan; Le Quesne, John; Nielsen, Torsten O.; Laenkholm, Anne-Vibeke; Fox, Stephen B.; Adam, Julien; Bartlett, John M. S.; Rimm, David L.; Quinn, Cecily; Peeters, Dieter; Dieci, Maria V.; Vincent-Salomon, Anne; Cree, Ian; Hida, Akira I.; Balko, Justin M.; Haynes, Harry R.; Frahm, Isabel; Acosta-Haab, Gabriela; Balancin, Marcelo; Bellolio, Enrique; Yang, Wentao; Kirtani, Pawan; Sugie, Tomoharu; Ehinger, Anna; Castaneda, Carlos A.; Kok, Marleen; McArthur, Heather; Siziopikou, Kalliopi; Badve, Sunil; Fineberg, Susan; Gown, Allen; Viale, Giuseppe; Schnitt, Stuart J.; Pruneri, Giancarlo; Penault-Llorca, Frederique; Hewitt, Stephen; Thompson, E. Aubrey; Allison, Kimberly H.; Symmans, William F.; Bellizzi, Andrew M.; Brogi, Edi; Moore, David A.; Larsimont, Denis; Dillon, Deborah A.; Lazar, Alexander; Lien, Huangchun; Goetz, Matthew P.; Broeckx, Glenn; El Bairi, Khalid; Harbeck, Nadia; Cimino-Mathews, Ashley; Sotiriou, Christos; Adams, Sylvia; Liu, Shi-Wei; Loibl, Sibylle; Chen, I-Chun; Lakhani, Sunil R.; Juco, Jonathan W.; Denkert, Carsten; Blackley, Elizabeth F.; Demaria, Sandra; Leon-Ferre, Roberto; Gluz, Oleg; Zardavas, Dimitrios; Emancipator, Kenneth; Ely, Scott; Loi, Sherene; Salgado, Roberto und Sanders, Melinda
(2020):
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
In: Journal of Pathology, Bd. 250, Nr. 5: S. 667-684
2019
Turner, Nicholas C.; Liu, Yuan; Zhu, Zhou; Loi, Sherene; Colleoni, Marco; Loibl, Sibylle; DeMichele, Angela; Harbeck, Nadia; Andre, Fabrice; Bayar, Mohamed Amine; Michiels, Stefan; Zhang, Zhe; Giorgetti, Carla; Arnedos, Monica; Bartlett, Cynthia Huang und Cristofanilli, Massimo
(2019):
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.
In: Journal of Clinical Oncology, Bd. 37, Nr. 14
2018
Powles, Ryan L.; Redmond, David; Sotiriou, Christos; Loi, Sherene; Fumagalli, Debora; Nuciforo, Paolo; Harbeck, Nadia; Azambuja, Evandro de; Sarp, Severine; Di Cosimo, Serena; Huober, Jens; Baselga, Jose; Piccart-Gebhart, Martine; Elemento, Olivier; Pusztai, Lajos und Hatzis, Christos
(2018):
Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer Secondary Analysis of the NeoALTTO Randomized Clinical Trial.
In: Jama Oncology, Bd. 4, Nr. 11, e181564
2017
Loibl, Sibylle; Turner, Nicholas C.; Ro, Jungsil; Cristofanilli, Massimo; Iwata, Hiroji; Im, Seock-Ah; Masuda, Norikazu; Loi, Sherene; Andre, Fabrice; Harbeck, Nadia; Verma, Sunil; Folkerd, Elizabeth; Theall, Kathy Puyana; Hoffman, Justin; Zhang, Ke; Bartlett, Cynthia Huang und Dowsett, Mitchell
(2017):
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.
In: Oncologist, Bd. 22, Nr. 9: S. 1028-1038
Fumagalli, Debora; Venet, David; Ignatiadis, Michail; Azim, Hatem A.; Maetens, Marion; Rothé, Francoise; Salgado, Roberto; Bradbury, Ian; Pusztai, Lajos; Harbeck, Nadia; Gomez, Henry; Chang, Tsai-Wang; Coccia-Portugal, Maria Antonia; Cosimo, Serena di; Azambuja, Evandro de; Peña, Lorena de la; Nuciforo, Paolo; Brase, Jan C.; Huober, Jens; Baselga, José; Piccart, Martine; Loi, Sherene und Sotiriou, Christos
(2017):
RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy A Secondary Analysis of the NeoALTTO Randomized Clinical Trial.
In: Jama Oncology, Bd. 3, Nr. 2: S. 227-234
2016
Cristofanilli, Massimo; Turner, Nicholas C.; Bondarenko, Igor; Ro, Jungsil; Im, Seock-Ah; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Zhang, Ke; Theall, Kathy Puyana; Jiang, Yuqiu; Bartlett, Cynthia Huang; Koehler, Maria und Slamon, Dennis
(2016):
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial.
In: Lancet Oncology, Bd. 17, Nr. 4: S. 425-439
Verma, Sunil; Bartlett, Cynthia Huang; Schnell, Patrick; DeMichele, Angela M.; Loi, Sherene; Ro, Jungsil; Colleoni, Fmarco; Iwata, Hiroji; Harbeck, Nadia; Cristofanilli, Massimo; Zhang, Ke; Thiele, Alexandra; Turner, Nicholas C. und Rugo, Hope S.
(2016):
Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).
In: Oncologist, Bd. 21, Nr. 10: S. 1165-1175